BDBM536510 7-(1-(2-((3-chloro-6- ((S)-4-ethyl-2-methyl- piperazin-1-yl)-2- fluoropyridin-4-yl) amino)-2-oxoethyl)- 7-methyl-4-oxo- 4,6,7,8-tetrahydro-1H- dipyrrolo[1,2-a:2',3'-d] pyrimidin-3-yl)-4- hydroxybenzo[d][1,3] dioxole-5-carboxamide::US11242351, Compound I-89

SMILES CCN1CCN([C@@H](C)C1)c1cc(NC(=O)Cn2cc(-c3cc(C(N)=O)c(O)c4OCOc34)c3c2nc2CC(C)Cn2c3=O)c(Cl)c(F)n1

InChI Key InChIKey=MRPXKUATZQNCKE-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 536510   

TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Human)
Ontario Institute For Cancer Research (Oicr)

US Patent
LigandPNGBDBM536510(7-(1-(2-((3-chloro-6- ((S)-4-ethyl-2-methyl- piper...)
Affinity DataKd:  1.36nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent